搜索结果11-20 的 25722 / ���������������������������op������r���:za33���
Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...
... (R/R) multiple myeloma (MM). A Study to Evaluate Pembrolizumab for Surgically Treated Adjuvant Merkel Cell Carcinoma. Rochester, Minn., Eau Claire, Wis. The ...
... (R/R) chronic lymphocytic leukemia (CLL). A Study of 3-D Digital Mammography to Screen Patients for Breast Cancer. Scottsdale/Phoenix, Ariz., Rochester, Minn ...
The current operative standard is to infiltrate the eye socket with 0.5% bupivacaine during surgery leading to several hours of postoperative analgesia. In ...
... (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international ... (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). A Study to Evaluate Encorafenib ...
... (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel ...
R. Robert Auger, M.D.. Rochester, MN. Michael R. Basso, Ph.
... (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM) administered once a day (QD) as a single agent and in combination with dexamethasone. Study of ...
... (R/R) multiple myeloma (MM). The Impact of a Geriatric Assessment in Elderly Patients with Multiple Myeloma. Rochester, Minn. The purpose of this study is to ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。